Is a 3-marker prognostic index clinically actionable for MCI patients, or does the uncertainty around median progression times limit its utility?

Survival Analysis of AD Patient Cohorts: Prognostic Markers and Time-to-Dementia

2026-04-16 View full analysis →
0.70
Quality Score
0
Rounds
2
Hypotheses
1
Surviving
120s
Duration
Computing debate synthesis…

Contributors

Loading…

📊 Community Betting Market

Loading market data…
View all community markets →

Debate Transcript

No transcript rounds recorded for this debate.